Aktie A14X6C K2X TECHNOLOGY & LIFE SCIENCE, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen K2X Technology & Life Science, Inc.

Aktien

A14X6C

US5015722003

KBPH

Markt geschlossen - OTC Markets
Andere Börsenplätze
 21:30:56 22.08.2022 		% 5 Tage % 1. Jan.
1 USD -45.65% Intraday Chart für K2X Technology & Life Science, Inc. -.--% -.--%
2022 Kyto Technology and Life Science, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Dezember 2021 CI
2021 Kyto Technology and Life Science, Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. September 2021 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
FluidAI Medical announced that it has received CAD 15 million in funding from a group of investors
Infinidome Ltd. announced that it has received $9 million in funding from Hanwha Aerospace Co., Ltd., Next Gear Ventures, Honeywell Ventures, VentureIsrael, Kyto Technology and Life Science, Inc., Aston Capital Management and another investor
Mrinq Technologies LLP announced that it has received $2.5 million in funding from a group of investors
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Kyto Technology & Life Science Inc. Announces the Termination of Tender Offer
Kyto Technology & Life Science Inc. Announces the Termination of Tender Offer
KYTO TECHNOLOGY & LIFE SCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-Q)
Kyto Technology and Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Unregistered Sale of Equity Securities (form 8-K)
Kyto Technology and Life Science, Inc. announced that it has received $2.620875 million in funding
Rhaeos, Inc. announced that it has received $2.2 million in funding from a group of investors
KYTO TECHNOLOGY & LIFE SCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-Q)
Kyto Technology and Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
Kyto Technology and Life Science : & LIFE SCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-Q/A)
Kyto Technology and Life Science : & LIFE SCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-Q)
Kyto Technology and Life Science, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2021
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Unregistered Sale of Equity Securities (form 8-K)
Kyto Technology and Life Science, Inc. announced that it has received $0.21 million in funding
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A14X6C Aktie
  4. Nachrichten K2X Technology & Life Science, Inc.
  5. Andere Sprachen